30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
Switzerland Biotechnology & Medical Research

Oculis Holding AG (OCS)

Track

Stock chart
Ticker: OCS Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Sherif Riad
Officer; CEO
1 sale — total 660,000 USD
Proposed sale 9 Mar 2026
Value US$794,123.04 | Price 35.95 | Shares 11,553
Proposed sale 9 Oct 2025
Value US$780,795.62 | Price 76.04 | Shares 65,312
Proposed sale 23 Sep 2025
Value US$442,500.00 | Price 17.70 | Shares 25,000
Proposed sale 14 Mar 2025
Value US$466,500.00 | Price 18.66 | Shares 25,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-03-09 2026-03-09 PrS Proposed sale
Sherif Riad

Officer; CEO

Officer
11,553
35.95
US$794,123 		11,553 35.95 US$794,123
2025-10-09 2025-10-09 PrS Proposed sale
2.2
CHRISTINA ACKERMANN

Director

Non-Executive Director
65,312
76.04
US$780,796 		65,312 76.04 US$780,796
2025-09-23 2025-09-23 PrS Proposed sale
Sherif Riad

Officer; CEO

Officer
97,322
52.80
US$169,808 		97,322 52.80 US$169,808
2025-03-14 2025-03-14 PrS Proposed sale
Sherif Riad

Officer; CEO

Officer
25,000
18.66
US$466,500 		25,000 18.66 US$466,500
Explore more

More insider trading research around Oculis Holding AG

More insider trades in Switzerland
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in Europe